Roy Buchanan
Stock Analyst at JMP Securities
(0.90)
# 2,692
Out of 4,479 analysts
33
Total ratings
35.29%
Success rate
-24.96%
Average return
Main Sectors:
Top Industries:
11 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GRTS Gritstone bio | Reiterates: Market Outperform | $5 | $0.58 | +762.07% | 3 | Jun 14, 2024 | |
| ENTA Enanta Pharmaceuticals | Maintains: Market Outperform | $23 → $22 | $13.07 | +68.32% | 7 | May 7, 2024 | |
| ABUS Arbutus Biopharma | Reiterates: Market Outperform | $4 | $3.12 | +28.21% | 4 | Apr 4, 2024 | |
| ANTX AN2 Therapeutics | Upgrades: Market Outperform | $6 | $2.13 | +181.69% | 3 | Apr 2, 2024 | |
| INO Inovio Pharmaceuticals | Initiates: Market Outperform | $12 | $8.61 | +39.37% | 1 | Jan 4, 2024 | |
| DVAX Dynavax Technologies | Maintains: Market Outperform | $25 → $27 | $11.16 | +141.94% | 5 | Nov 3, 2023 | |
| CVAC CureVac | Maintains: Outperform | $34 → $24 | $3.33 | +620.72% | 4 | Apr 26, 2023 | |
| ESPR Esperion Therapeutics | Reiterates: Market Outperform | $15 | $2.34 | +541.03% | 1 | Mar 6, 2023 | |
| ARGX argenx SE | Maintains: Market Outperform | $443 → $448 | $434.22 | +3.17% | 2 | Mar 3, 2023 | |
| CRMD CorMedix | Maintains: Market Perform | $14 → $16 | $4.28 | +273.83% | 1 | Mar 1, 2023 | |
| IBIO iBio, Inc. | Downgrades: Market Perform | n/a | $2.02 | - | 2 | Feb 16, 2023 |
Gritstone bio
Jun 14, 2024
Reiterates: Market Outperform
Price Target: $5
Current: $0.58
Upside: +762.07%
Enanta Pharmaceuticals
May 7, 2024
Maintains: Market Outperform
Price Target: $23 → $22
Current: $13.07
Upside: +68.32%
Arbutus Biopharma
Apr 4, 2024
Reiterates: Market Outperform
Price Target: $4
Current: $3.12
Upside: +28.21%
AN2 Therapeutics
Apr 2, 2024
Upgrades: Market Outperform
Price Target: $6
Current: $2.13
Upside: +181.69%
Inovio Pharmaceuticals
Jan 4, 2024
Initiates: Market Outperform
Price Target: $12
Current: $8.61
Upside: +39.37%
Dynavax Technologies
Nov 3, 2023
Maintains: Market Outperform
Price Target: $25 → $27
Current: $11.16
Upside: +141.94%
CureVac
Apr 26, 2023
Maintains: Outperform
Price Target: $34 → $24
Current: $3.33
Upside: +620.72%
Esperion Therapeutics
Mar 6, 2023
Reiterates: Market Outperform
Price Target: $15
Current: $2.34
Upside: +541.03%
argenx SE
Mar 3, 2023
Maintains: Market Outperform
Price Target: $443 → $448
Current: $434.22
Upside: +3.17%
CorMedix
Mar 1, 2023
Maintains: Market Perform
Price Target: $14 → $16
Current: $4.28
Upside: +273.83%
iBio, Inc.
Feb 16, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $2.02
Upside: -